Musculoskeletal Oncology

Steensma Laboratory
The Steensma Laboratory conducts research that aims to develop new treatment strategies for sarcomas. Specifically, the lab is interested in determining the mechanisms underlying tumor formation in sporadic bone and soft tissue sarcomas and in neurofibromatosis type 1, a hereditary disorder caused by mutations in the neurofibromin 1 (NF1) gene.

Learn More